Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Clinical
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint…
Clinical
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Commercial
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
CannTrust Announces Launch of New Medical Brand estora – FirstWord Pharma
Clinical
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA…
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Home
Therapy areas
Dermatology
Dermatology
Cardio-metabolism
Dermatology
Gastroenterology
Genitourinary
Haematology
Immuno-inflammation
Immuno-oncology
Infectious diseases
Musculoskeletal
Neurology
Nutritional Supplements
Ophthalmology
Orphan-paediatric
Others
Psychiatry
Respiratory
Vaccine
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Dermatology
Vanda Reports results from the EPIONE study of Tradipitant in the treatment of Pruritus in Atopic Dermatitis
Biospace News
-
February 25, 2020
Dermatology
Incyte’s ruxolitinib cream achieves main goal in second late-stage atopic dermatitis study
Firstwordpharma News
-
February 19, 2020
Dermatology
Incyte’s ruxolitinib cream achieves main goal in second late-stage atopic dermatitis...
Firstwordpharma News
-
February 19, 2020
0
Dermatology
Incyte’s Big Dermatitis Week: Ruxolitinib and Baricitinib Hit Primary Endpoints
Biospace News
-
January 28, 2020
0
Dermatology
Incyte’s cream formulation of ruxolitinib hits main goal of late-stage atopic...
Firstwordpharma News
-
January 28, 2020
0
Dermatology
Concert Pharmaceuticals Successfully Completes Open Label Trial of CTP-543 in Patients...
Firstwordpharma News
-
December 19, 2019
0
Dermatology
LEO Pharma’s experimental drug tralokinumab hits main goals of three pivotal...
Firstwordpharma News
-
December 11, 2019
0
1
2
3
...
5
Page 1 of 5
- Advertisement -
LATEST NEWS
Annual Report to the Nation: Cancer death rates continue to decline – FirstWord Pharma
Firstwordpharma News
-
March 13, 2020
0
Aro Biotherapeutics and Ionis Enter Licensing and Collaboration Agreement Focused on Cell-Specific Delivery of Antisense Oligonucleotides
January 9, 2020
BioSpace Global Roundup, July 18
July 18, 2019
MUST READ
Origenis GmbH Announces Global License and Collaboration Agreement with Expansion Therapeutics for Novel Therapies...
Pipeline Review News
-
January 24, 2019
0
Merck KGaA, Darmstadt, Germany, Grants Exclusive License to Vertex for Two DNA Damage Response...
Firstwordpharma News
-
January 24, 2019
0
First Proof CRISPR Can Be Safe in Cancer Therapy
Biospace News
-
February 7, 2020
0
Load more
